---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-028292"
form_type: "8-K"
ticker: "SONM"
cik: "0001178697"
company_name: "DNA X, Inc."
filed_at: "2025-12-18T23:59:59+00:00"
generated_at: "2026-05-16T12:42:36.928564+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Sonim issues $1.2M convertible note, acquires DNA X DeFi protocol for 19.99% stock

## Summary
- Issued $1.2M convertible promissory note to DNA Holdings, 10% interest, due Dec 2026, convertible at $5.50/share.
- Acquired 100% of DNA X LLC for 223,201 shares (19.99% of outstanding) – an on-chain DeFi trading protocol.
- DNA Holdings receives board nomination rights (1 officer, 1 director) if it holds ≥5% of common stock.
- Put option: if DNA X doesn't hit $600M volume or $1M/day revenue by June 2026, DNA Holdings can swap shares back for DNA X.
- Exchanged $629,640 of Streeterville note for 148,500 shares at $4.24; remaining Streeterville note ~$2.3M.

## SEC filing metadata
- accession: 0001493152-25-028292
- form_type: 8-K
- ticker: SONM
- cik: 0001178697
- company_name: DNA X, Inc.
- filed_at: 2025-12-18T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 2.01, 2.03, 3.02, 3.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1178697/000149315225028292/0001493152-25-028292-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1178697/000149315225028292/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-028292
- JSON: https://secwatch.observer/filing/0001493152-25-028292.json
- Plain text: https://secwatch.observer/filing/0001493152-25-028292.txt

## Source-grounded claims
- claim_id: 58ba76a03e7af73bba7bbe3e72103dd548a72e6f
  claim: DNA X, Inc. incurred convertible notes of $1,200,000 with DNA Holdings Venture, Inc. at 10% per annum maturing December 15, 2026.
  evidence_excerpt: issued a convertible promissory note in the original principal amount of $1,200,000 (the “DNA Note”)
  evidence_url: https://www.sec.gov/Archives/edgar/data/1178697/000149315225028292/0001493152-25-028292-index.htm
- claim_id: ccf2ddcc39758bc2d19769facd13a3ebe740bff2
  claim: DNA X, Inc. completed an acquisition involving DNA Holdings Venture, Inc. for 223,201 shares of the Company’s common stock, representing 19.99% of the outstanding shares of the Company’s common stock as of the date of issuance (closed 2025-12-15).
  evidence_excerpt: the Company purchased 100% of the membership interests in DNA X LLC, a Delaware limited liability company, (“DNA X”) for an aggregate purchase price of 223,201 shares of the Company’s common stock, representing 19.99% of the outstanding shares of the Company’s common stock as of the date of issuance.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1178697/000149315225028292/0001493152-25-028292-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.